Evidence map›Paper›PMID 42912009›Full record

ArticleActa cirurgica brasileira2026

Exosome-mediated immunomodulatory and barrier-protective responses of adipose-derived mesenchymal stem cells in oleic acid-induced acute lung injury.

Gamze Ayar, Badel Ince, Kansu Buyukafsar, Leyla Bahar, Elif Onsoz, Erkan Maytalman, Mehmet Oguz Koksel

Abstract read
In one paragraph

Article in Acta cirurgica brasileira, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gamze AyarMersin University - Institute of Health Sciences - Department of Stem Cell and Regenerative Medicine - Mersin - Turkey.ORCID http://orcid.org/0000-0002-5288-4755
Badel InceMersin University - Institute of Health Sciences - Department of Stem Cell and Regenerative Medicine - Mersin - Turkey.ORCID http://orcid.org/0000-0002-0004-3567
Kansu BuyukafsarMersin University - Institute of Health Sciences - Department of Stem Cell and Regenerative Medicine - Mersin - Turkey.ORCID http://orcid.org/0000-0003-4117-6013
Leyla BaharMersin University - Institute of Health Sciences - Department of Stem Cell and Regenerative Medicine - Mersin - Turkey.ORCID http://orcid.org/0000-0002-6910-6167
Elif OnsozMersin University - Institute of Health Sciences - Department of Stem Cell and Regenerative Medicine - Mersin - Turkey.ORCID http://orcid.org/0000-0001-5665-8985
Erkan MaytalmanAlanya Alaaddin Keykubat University - Faculty of Medicine - Department of Medical Pharmacology - Antalya - Turkey.ORCID http://orcid.org/0000-0001-5284-7439
Mehmet Oguz KokselMersin University - Faculty of Medicine - Department of Thoracic Surgery - Mersin - Turkey.ORCID http://orcid.org/0000-0002-4340-9725

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAcute lung injury (ALI) is a severe pulmonary disorder with limited treatment options. Mesenchymal stem cell-based therapies show regenerative and immunomodulatory potential, but the comparative efficacy of adipose-derived mesenchymal stem cells (ADMSCs) and their exosomes remains unclear. This study evaluated their therapeutic effects in an experimental ALI model.

methodsADMSCs were isolated from rat adipose tissue and cultured under standard conditions. Exosomes were characterized by flow cytometry (CD9, CD63, CD81), scanning electron microscopy, dynamic light scattering, and zeta potential analysis. ALI was induced in Wistar Albino rats by intravenous administration of 60 mg/kg oleic acid. Treatments were administered 2.5 hours after injury. Lung tissues were examined histopathologically after 24 hours, and mRNA expression levels of interleukin (IL)-6, IL-10, and vascular endothelial growth factor (VEGF) were analyzed.

resultsBoth ADMSC and exosome treatments significantly reduced lung injury scores compared with the oleic acid group. ADMSCs demonstrated greater histopathological improvement than exosomes, although no significant differences were observed in IL-6, IL-10, or VEGF expression.

conclusionBoth ADMSCs and their exosomes showed therapeutic potential in ALI, with stem cells providing superior histopathological recovery.

Indexed as

Acute Lung InjuryAdipose TissueExosomesMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAnimalsDisease Models, AnimalFlow CytometryInterleukin-10Interleukin-6LungMaleMicroscopy, Electron, ScanningOleic AcidRatsRats, WistarInterleukin-10Interleukin-6Oleic AcidVascular Endothelial Growth Factor A

Identifiers

PMID42912009
PMCPMC13686608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.